Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population

Atrial fibrillation (AF) is the most common arrhythmia in the clinical setting and an independent risk factor for stroke. Approximately 10 million Chinese people are affected by AF, but the genetic basis is largely unknown. A recent genome-wide association study in Iceland identified association between SNP rs2200733 on 4q25 and AF; however, many independent replication studies are essential to unequivocally validate this association. To assess the association between rs2200733 and AF as well as that between rs2200733 and ischemic stroke in a mainland Chinese Han population, we carried out case–control association studies with 383 AF patients versus 851 non-AF controls and 811 ischemic stroke patients versus 688 non-stroke controls. Highly significant association was detected between rs2200733 and AF in a Chinese Han population (allelic P = 3.7 × 10−11 with OR = 1.81; genotypic P = 4.1 × 10−12 with a dominant model). When the AF cases were divided into lone AF (32.6%) and other types of AF (67.4%), significantly stronger association was found with lone AF (OR = 2.40, P = 1.3 × 10−9 compared to OR = 1.59, P = 6.2 × 10−7 for other types of AF; P = 0.02 for two ORs). No significant association was found between rs2200733 and ischemic stroke. Our results suggest that SNP rs2200733 confers a highly significant risk of AF, but not ischemic stroke, in a more representative Chinese Han population in the mainland China.

[1]  D. Hu,et al.  Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. , 2008, Journal of the American College of Cardiology.

[2]  C. Gieger,et al.  Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke , 2008, Annals of neurology.

[3]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[4]  L. Lai,et al.  Molecular genetics of atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[5]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[6]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[7]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[8]  José Jalife,et al.  Atrial fibrillation : from bench to bedside , 2008 .

[9]  Lippincott Williams Wilkins,et al.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. , 1989, Stroke.

[10]  Jiunn-Lee Lin,et al.  Molecular Genetic Studies in Atrial Fibrillation , 2003, Cardiology.

[11]  Ramon Brugada,et al.  Short QT Syndrome and Atrial Fibrillation Caused by Mutation in KCNH2 , 2005, Journal of cardiovascular electrophysiology.

[12]  Martin Bienengraeber,et al.  Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. , 2006, Human molecular genetics.

[13]  Yusong He,et al.  A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. , 2005, Biochemical and biophysical research communications.

[14]  S. Bendahhou,et al.  Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. , 2004, American journal of human genetics.

[15]  D. Hu,et al.  An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China , 2008, Journal of epidemiology.

[16]  Q. Wang Atrial Fibrillation Genetic Considerations: The Basic Scientist's Perspective , 2008 .

[17]  Thomas Meitinger,et al.  Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. , 2008, European heart journal.

[18]  S. Lévy,et al.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[19]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[20]  M. Komajda,et al.  Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations , 2003, Journal of medical genetics.

[21]  T. Ke,et al.  Mutation in Nuclear Pore Component NUP155 Leads to Atrial Fibrillation and Early Sudden Cardiac Death , 2008, Cell.

[22]  J. Ruskin,et al.  Familial aggregation in lone atrial fibrillation , 2005, Human Genetics.

[23]  K. Stefánsson,et al.  Familial aggregation of atrial fibrillation in Iceland. , 2006, European heart journal.

[24]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[25]  M. de Andrade,et al.  Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. , 2008, The New England journal of medicine.

[26]  Wei Huang,et al.  KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation , 2003, Science.

[27]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.